K05
Conditions
Interventions
Group 1: Test-PB: electric toothbrush + App (within the SRP 6 weeks)
Group 2: Test-MB: manual toothbrush +App (within the SRP 6 weeks)
Group 3: Control-PB: electric toothbrush without App (within th
Sponsors
Klinik für Zahnerhaltungs und Parodontologie
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: - written informed consent for study participation, specifically of data recording during oral hygiene at home by the study toothbrushes. - generalized periodontitis = Stage I. - patient age 18 to 80 years - are in good general health - Have at least 14 teeth (excluding implants); - agree not to participate in any other oral care clinical trial during the study period; - agree not to use other toothbrushes and dentifrices than the study products during the study period; - Subject will use interdental space hygiene aids such as dental floss, interdental brushes, etc., but agrees not to use or change other oral hygiene products, including whiteners, etc.; - agree to follow study procedures and attend all scheduled clinical visits; - agree to refrain from elective dental treatments during the study, such as teeth whitening, orthodontic tooth movement, etc., that are not part of the study protocol; - availability of an internet and app-enabled smartphone or tablet.
Exclusion criteria
Exclusion criteria: - Patient is younger than 18 or older than 80 years of age; - failure of patient to give informed consent for student treatment during non-surgical therapy; - currently or enrolled within the past 30 days in another oral care clinical trial; - dentists or dental students, dental assisting personnel; - disease, condition, or medical condition that could reasonably be expected to interfere with the study procedures or affect or prevent the safe conduct of the study (e.g., chemotherapy, AIDS, diabetes mellitus, epilepsy, tremor, Parkinson's disease, dementia); - physical limitations that might preclude normal oral hygiene; - self-reported pregnancy or breastfeeding; - taking medications for at least three consecutive days within the last 28 days that could affect the outcome of the study (e.g., anti-inflammatory medications, Dilantin, NSAIDs); - current use of medications that may cause gingival hyperplasia (e.g., calcium antagonists such as nifedepine, hydantoin, ciclosporin); - has a known allergic reaction to dental materials or oral hygiene products; - who require medication of any kind prior to dental procedures; - evidence of major hard or soft tissue lesions or trauma or carious lesions requiring restorative treatment; - active orthodontic treatment; - smokers with >10 cigs/d.; - Patients who do not own a smartphone/tablet; - professional tooth cleaning within the last 4 weeks prior to study entry
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of gingival bleeding index (?GBI) collected at baseline (1), visits (2-5), endpoint (6) each weekly | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in time spent on oral hygiene, brushing-systematic, -motivationand -behavior, pocket depths (?PD), recessions (?Rez), bleeding onprobing (?BOP), calculated clinical attachment level (?CAL), total plaqueindex (?PCR) collected at baseline (1), visits (2-5), endpoint (6) each weekly | — |
Countries
Germany
Contacts
Public ContactChristian Graetz
Klinik für Zahnerhaltung und Parodontologie
Outcome results
None listed